Ivor Elrifi
Vermogen: 4 M $ op 31-05-2026
Vermogen: 4 M $ op 31-05-2026
Ivor Elrifi is Chief Executive Officer & Executive Director at Tiziana Life Sciences Ltd. since 2024.
Formerly, Dr. Elrifi was Global Head-Patent at Cooley LLP from 2014 to 2024 and Global Head-Patents at Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC from 1999 to 2014.
Education includes undergraduate and doctorate degrees from Queen's University and a graduate degree from Osgoode Hall Law School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 2.687.248 ( 2,26% ) | 4 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Algemeen Directeur | 19-08-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01-08-2024 |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01-01-2014 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Osgoode Hall Law School
Osgoode Hall Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau